Baricitinib Interactions
There are 484 drugs known to interact with baricitinib, along with 10 disease interactions. Of the total drug interactions, 334 are major, 143 are moderate, and 7 are minor.
- View all 484 medications that may interact with baricitinib
- View baricitinib disease interactions (10)
Most frequently checked interactions
View interaction reports for baricitinib and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Augmentin (amoxicillin / clavulanate)
- Azithromycin Dose Pack (azithromycin)
- Brevital Sodium (methohexital)
- Celebrex (celecoxib)
- Diltiazem Hydrochloride SR (diltiazem)
- Eliquis (apixaban)
- Entresto (sacubitril / valsartan)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- GamaSTAN S/D (immune globulin intramuscular)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Morphine Sulfate ER (morphine)
- Nexium (esomeprazole)
- Panadol Osteo (acetaminophen)
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
Baricitinib disease interactions
There are 10 disease interactions with baricitinib which include:
- infections
- tuberculosis
- cardiovascular risk
- malignancy
- thrombosis
- GI perforation
- hepatic impairment
- laboratory abnormalities
- renal dysfunction
- viral hepatitis
More about baricitinib
- baricitinib consumer information
- Compare alternatives
- Reviews (15)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.